Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: A subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trials

Hematological Oncology, EarlyView.
Source: Hematological Oncology - Category: Hematology Source Type: research